Ezetimibe and Atorvastatin Therapy on TCFA
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT02588235
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT02588235
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT02588235. Randomized; no masking; primary purpose prevention. Start 2015-10 (registry gives no type); primary completion 2017-11 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Ezetimibe and Atorvastatin Therapy on TCFA
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Ezetimibe and Atorvastatin
- Intervention (Drug)
- Atorvastatin
- Lead sponsor
- Xijing Hospital
Record details
- Record id
cardio:ct-nct02588235- Content hash
4b374d74b12229de0ae7ca040d6ed1542908749534fe0a90dc2ef2407a5d3873